Exploratory study on mechanism of action and immune-related biomarkers in patients with salivary gland cancer who received trastuzumab delxteca
Not Applicable
- Conditions
- salivary gland carcinoma
- Registration Number
- JPRN-UMIN000044278
- Lead Sponsor
- Hokkaido University Hospital Medical oncology
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 52
Inclusion Criteria
Not provided
Exclusion Criteria
No criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Immune cell profile analysis Genome mutation analysis mRNA expression analysis Proteomics analysis Multicolor IHC analysis AI pathological analysis Blood cfDNA analysis Blood cfRNA / miRNA analysis, etc.
- Secondary Outcome Measures
Name Time Method